These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 24220281
1. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis. Pendyala LK, Minha S, Barbash IM, Torguson R, Magalhaes MA, Okubagzi P, Loh JP, Chen F, Satler LF, Pichard AD, Waksman R. Am J Cardiol; 2014 Jan 15; 113(2):342-7. PubMed ID: 24220281 [Abstract] [Full Text] [Related]
5. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Dewey TM, Bowers B, Thourani VH, Babaliaros V, Smith CR, Leon MB, Svensson LG, Tuzcu EM, Miller DC, Teirstein PS, Tyner J, Brown DL, Fontana GP, Makkar RR, Williams MR, George I, Kirtane AJ, Bavaria JE, Mack MJ. Ann Thorac Surg; 2013 Dec 15; 96(6):2083-9. PubMed ID: 23968764 [Abstract] [Full Text] [Related]
6. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). Chieffo A, Buchanan GL, Van Mieghem NM, Tchetche D, Dumonteil N, Latib A, van der Boon RM, Vahdat O, Marcheix B, Farah B, Serruys PW, Fajadet J, Carrié D, de Jaegere PP, Colombo A. J Am Coll Cardiol; 2013 Feb 26; 61(8):830-6. PubMed ID: 23333140 [Abstract] [Full Text] [Related]
7. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson LG, Tuzcu EM, Xu K, Minha S, Alu MC, Szeto WY, Thourani VH, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD. J Am Coll Cardiol; 2014 Jan 28; 63(3):269-79. PubMed ID: 24140659 [Abstract] [Full Text] [Related]
8. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. Circulation; 2011 Jul 26; 124(4):425-33. PubMed ID: 21747054 [Abstract] [Full Text] [Related]
9. Two-year outcomes for patients with severe symptomatic aortic stenosis treated with transcatheter aortic valve implantation. Codner P, Assali A, Dvir D, Vaknin-Assa H, Porat E, Shapira Y, Kupershmidt M, Bental T, Battler A, Sagie A, Kornowski R. Am J Cardiol; 2013 May 01; 111(9):1330-6. PubMed ID: 23415022 [Abstract] [Full Text] [Related]
11. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Durand E, Eltchaninoff H, Canville A, Bouhzam N, Godin M, Tron C, Rodriguez C, Litzler PY, Bauer F, Cribier A. Am J Cardiol; 2015 Apr 15; 115(8):1116-22. PubMed ID: 25726383 [Abstract] [Full Text] [Related]